The Possible Crosstalk of MOB2 With NDR1/2 Kinases in Cell Cycle and DNA Damage Signaling by Hergovich, A
The Possible Crosstalk of MOB2 With NDR1/2 Kinases in Cell Cycle and DNA
Damage Signaling
Ramazan Gundogdu and Alexander Hergovich*
Tumour Suppressor Signaling Networks Laboratory, UCL Cancer Institute, University College London, UK
*Corresponding author: Alexander Hergovich, UCL Cancer Institute, University College London, 72 Huntley Street, WC1E 6BT, London, United Kingdom, Tel: +44 20
7679 0723; Fax: +44 20 7679 6817; E-mail: a.hergovich@ucl.ac.uk
Received date: August 4, 2016, Accepted date: September 01, 2016, Published date: September 06, 2016
Copyright: © 2016 Gundogdu R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
This article is the authors’ opinion of the roles of the signal transducer Mps one binder 2 (MOB2) in the control of
cell cycle progression and the DNA Damage Response (DDR). We recently found that endogenous MOB2 is
required to prevent the accumulation of endogenous DNA damage in order to prevent the undesired, and possibly
detrimental, activation of cell cycle checkpoints. In this regard, it is noteworthy that MOB2 has been linked
biochemically to the regulation of the NDR1/2 (aka STK38/STK38L) protein kinases, which themselves have
functions at different steps of the cell cycle. Therefore, we are speculating in this article about the possible
connections of MOB2 with NDR1/2 kinases in cell cycle and DDR Signaling.
Keywords: Cell cycle progression; DNA damage signaling; mps one
binder; Nuclear Dbf2-related kinase; Serine/threonine protein kinase
38; Phosphorylation; Protein-protein interaction
Introduction
The family of Mps one binder proteins (MOBs) is highly conserved
in eukaryotes [1]. MOBs represent signal transducers in essential
intracellular Signaling pathways through their regulatory interactions
with serine/threonine protein kinases of the NDR/LATS family [1-3].
In budding and fission yeast, Mob1p and Mob2p are crucial for mitotic
exit and cell morphogenesis as regulators of the yeast NDR/LATS
kinases Dbf2p, Cbk1p, Sid2p and Orb6p, respectively [4-6]. In
Drosophila, three different MOB proteins are expressed by
independent genes, with dMOB1 (aka Mats) functioning as a core
component of the Hippo tumor suppressor pathway as regulator of the
fly LATS kinase Warts [7-9]. Drosophila MOB2 (dMOB2) contributes
to neuromuscular junction and photoreceptor morphology [10,11] and
the biological function(s) of dMOB3 is currently unknown, although
all three dMOBs can genetically interact with the fly NDR kinase
Tricornered [12]. Mammalian genomes contain at least six different
MOB genes termed MOB1A, MOB1B, MOB2, MOB3A, MOB3B and
MOB3C [1]. MOB1A/B likewise to dMOB1 functions as a regulator of
LATS kinases in mammalian Hippo signaling [1,2], although current
evidence proposes that the interaction of MOB1 with NDR kinases is
likely to also play a role in Hippo signaling [3].
In contrast to MOB1, MOB2 interacts specifically with NDR, but
not with LATS kinases in mammalian cells [13-15]. MOB3A/B/C
neither form a complex with NDR nor LATS kinases, but instead
associate with the pro-apoptotic kinase MST1 (aka STK4) [16]. Taken
together, throughout the eukaryotic kingdom MOBs can play diverse
roles as regulators of members of the NDR/LATS kinase family and
apparently also other protein kinases in specific settings. In this article
we will focus on discussing recent discoveries regarding roles of
endogenous MOB2 in cell cycle progression and the DNA damage
response (DDR) in the context NDR kinase signaling. Up to recently
[17], mammalian NDR kinases were the only reported binding
partners of MOB2 [1,15]. More precisely, biochemical experiments
showed that MOB2 competes with MOB1 for NDR binding, with the
MOB1/NDR complex corresponding to increased NDR kinase activity
and the MOB2/NDR complex being associated with diminished NDR
activity [15]. In other words, MOB2 binding to NDR can block the
activation of NDR kinases. However, the biological significance of
MOB2/NDR complex formation is currently unknown. Actually, no
clearly defined physiologically relevant functions of endogenous
MOB2 were known until recently. Therefore, we set out to understand
important cell biological roles of endogenous MOB2. Intriguingly, a
genome wide screen for novel putative DDR factors identified MOB2
(also termed HCCA2 and hMOB3 [1]) as one of many potential
candidates [18]. Considering that the DDR is essential to maintain
genome stability and functions as a barrier for ageing and
tumorigenesis [19], we investigated whether MOB2 is indeed a DDR
protein. Intriguingly, we initially found that MOB2 knockdown, but
not MOB2 overexpression, caused a cell proliferation defect associated
with a G1/S cell cycle arrest in untransformed human cells [17].
By profiling an array of cell cycle markers we discovered that
MOB2-depleted cells displayed a significant activation of the p53 and
p21/Cip1 cell cycle regulators, which was functionally relevant, since
co-knockdown of p53 or p21 together with MOB2 did not result in the
activation of the G1/S cell cycle checkpoint, consequently restoring cell
proliferation [17]. Once we had established that MOB2 knockdown
causes the activation of a p53/p21-dependent G1/S cell cycle
checkpoint, we wondered how this activation occurred. Considering
that endogenous MOB2 is potentially linked to the DDR [18] and that
activation of the p53/p21 pathway can occur upon activation of DDR
signaling [20-22], we studied the levels of DDR Signaling and
endogenous DNA damage in MOB2-depleted cells [17]. These
investigations revealed that MOB2 knockdown causes the
accumulation of DNA damage, and consequently activation of the
DDR kinases ATM and CHK2, in the absence of exogenously induced
DNA damage. Next, we aimed to consolidate these findings by
studying the response of MOB2 knockdown cells to exogenously
induced DNA damage. This showed that endogenous MOB2 is needed
to promote cell survival and G1/S cell cycle arrest upon exposure to
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DNA damaging agents such as ionizing radiation (IR) or the
topoisomerase II poison doxorubicin [17]. Moreover, we discovered
that MOB2 is required to support IR-induced DDR Signaling through
the DDR kinase ATM.
Figure 1: Molecular processes that are possibly regulated by
connected MOB2 and NDR1/2 signaling the MOB2 signal
transducer acts in the DNA damage response (DDR) pathway by
supporting MRN-ATM Signaling [17]. MOB2 can also interact with
the NDR1/2 serine/threonine protein kinases and thereby interfere
with the activation of NDR1/2 by MOB1 binding [15]. However, it
is currently not known whether the associations of MOB2 (or
MOB1) with NDR1/2 are functionally relevant for the regulation of
NDR1/2 substrates such as the cell cycle regulator p21/Cip1, the
CDC25A phosphatase, or heterochromatin protein 1α (HP1α, also
known as CBX5), whose NDR1/2-mediated phosphorylation can
play roles in G1/S cell cycle transition [30], the DNA damage G2/M
cell cycle checkpoint [41], or mitotic progression [37], respectively
Collectively, these observations uncovered endogenous MOB2 as a
novel DDR factor that plays a role in DDR Signaling, cell survival and
cell cycle checkpoints upon exposure to DNA damage. However, we
still had not understood how MOB2 may function as DDR protein on
a molecular level. In this regard, using a yeast two-hybrid screen we
had identified RAD50 as a novel binding partner of MOB2 [17], which
potentially was important, since RAD50 is a central component of the
essential MRE11-RAD50-NBS1 (MRN) DNA damage sensor complex,
which in turn is crucial for the sequestering/activation of the DDR
kinase ATM at DNA lesions [23-25]. Therefore, we examined this
potential interaction in more detail, revealing that MOB2/RAD50
complex formation can be detected using exogenous and endogenous
proteins [17]. Moreover, we found that MOB2 supports the
recruitment of MRN and activated ATM to DNA damaged chromatin,
suggesting that MOB2-depleted cells display a defective DDR due to
impaired functionality of the MRN [17]. However, although we could
map the binding sites of MOB2 on RAD50 to two functionally relevant
domains of RAD50 [17], we did not succeed in identifying MOB2
variants carrying single point mutations that block MOB2/RAD50
complex formation [Gomez V and Hergovich A, unpublished
observation], which would have enabled us to investigate the
functional significance of the MOB2/RAD50 interaction in more
detail. Therefore, our study [17] could not conclusively establish that
the interaction of MOB2 with RAD50 is functionally essential for the
roles of MOB2 in DDR Signaling, cell survival and cell cycle
checkpoints upon exposure to DNA damage.
In this regard, it is noteworthy that in the genome wide screen
performed by Elledge et al. [18] the knockdown of MRN components
did not result in DDR defects (as judged by sensitivity to mitomycin C
and a defective G2/M DNA damage checkpoint) as observed in
MOB2-depleted transformed human cells [18]. Thus, the link of MOB2
to the MRN does not appear to be relevant in all DDR settings,
suggesting that additional mechanisms should be considered. In
general, we have only begun to appreciate the cell biological functions
of endogenous MOB2 in processes that are relevant to human health
and disease. In particular regarding the link of MOB2 with the DDR,
quite a few key questions are yet to be understood. For example, we
have yet to comprehend which types of DNA damage repair
mechanism(s) [26,27] is dependent on normal MOB2 levels. Maybe
the expression/localization status of MOB2 has the potential to be
clinically exploited for the prediction and/or prognosis of responses to
DNA damaging agents (i.e. radiotherapy, DNA damaging
chemotherapeutics, targeted DDR inhibition, and others).
Furthermore, we have yet to obtain a clear mechanistic understanding
of how MOB2 can function as a DDR protein and how MOB2 is
regulated in a context-dependent manner.
Currently, we are far from grasping all these important concepts.
Nevertheless, our previous [1,15] biochemical characterization of
MOB2 in complex with the NDR1/2 kinases may be of help to lead
some of the way. However, based on our own experiments we already
speculated that MOB2 apparently functions as cell cycle/DDR
regulator independently of NDR1/2 kinase Signaling [17]. More
specifically, we observed that knockdown of NDR1 (aka STK38) or
NDR2 (STK38L) in untransformed human cells did not trigger a p53/
p21-dependent G1/S cell cycle arrest as observed in MOB2-depleted
cells [17]. Overexpression of hyperactive NDR1-PIF [28] also did not
cause an obvious cell cycle/proliferation defect [17]. However, we
believe that further investigations are still required to completely rule
out that NDR1/2 Signaling is not linked to cell cycle/DDR processes
through MOB2, since different reports have recently linked the
NDR1/2 kinases to cell cycle and DDR signaling [3]. In addition,
compensatory mechanisms may occur upon selective NDR1 or NDR2
manipulations. In mammals, the NDR1/2 protein kinases have been
linked to cell biological processes such as cell cycle progression, the
DDR, apoptosis, stress signaling and autophagy, with important roles
in embryogenesis, immunology and neurobiology [3]. As mentioned
above, in particular the connections of NDR1/2 with the cell cycle and
DDR are intriguing with respect to MOB2 (Figure 1). On the one
hand, NDR1/2 are linked to the regulation of G1/S cell cycle
progression by controlling protein levels of c-myc and p21/Cip1
[29-32]. The role of NDR1/2 in the G1/S cell cycle progression is
further supported by cyclin D1 [33] and can have a role in opposing a
TGFβ-mediated cell cycle arrest [34]. Furthermore, NDR1 has
important functions in mitosis [35-38]. Thus, various tissue culture cell
experiments support the notion that NDR1/2 can play diverse roles in
the regulation of cell cycle progression. On the other hand, NDR1 has
been linked to different aspects of the DDR. NDR1-depleted
transformed human cells have increased sensitivity to IR [39]. NDR1
possibly has a function in nucleotide excision repair, a specific type of
DNA damage repair [40]. In addition, NDR1 potentially is involved in
the DNA damage induced G2/M cell cycle checkpoint by
phosphorylating the CDC25A phosphatase [41], although this
phosphorylation of CDC25A is also mediated by the DDR kinase
CHK1 [42], hence warranting future investigations into this possible
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link of NDR1 and the DNA damage induced G2/M cell cycle
checkpoint. Taken together, current evidence suggests that the NDR1/2
kinase pathway is linked to the regulation of certain aspects of cell
cycle progression and signal transduction in response to DNA damage
(Figure 1).
Nevertheless, in spite of the involvement of NDR1/2 in the cell cycle
and DDR [3] in a similar fashion as observed for MOB2 [17,18], it is
currently unknown whether the MOB2 and NDR1/2 pathways are
functionally connected, as suggested by our recent biochemical
evidence [15]. In this regard, we can envision different scenarios.
Based on our biochemical understanding [15], MOB2 may act
upstream of NDR1/2 by functioning as inhibitor of MOB1-mediated
NDR1/2 signaling. However, simply based on our current lack of
evidence, we should not exclude the possibility that NDR1/2 may play
a role upstream of MOB2, in which case it would be very informative
to understand the involvement of the NDR1/2 kinase activity, in
addition to the regulation of MOB2 by NDR1/2 (or vice versa) through
direct protein-protein interactions. In this regard, experimenters
should also keep in mind that single NDR1 or NDR2 knockdown
compared to co-depletion of NDR1 and NDR2 may result in different
phenotypes due to possible compensatory mechanisms [43]. More
specifically, we found that single NDR1 or NDR2 knockout mice are
viable and fertile due to compensatory tissue specific up regulation of
NDR2 or NDR1, respectively [43,44]. In contrast, NDR1/2 double-
knockout mice die before birth around embryonic day E10 [43]. These
findings collectively suggest that NDR1 and NDR2 can compensate for
each other in a context- and tissue-specific fashion [43,44]. In case
MOB2 functions negatively upstream of NDR1/2 in DDR signaling,
one would expect that MOB2 knockdown or hyperactivation of
NDR1/2 result in similar phenotypes, which does not seem to be the
case [17]. If NDR1/2 were to act upstream of MOB2 in DDR Signaling,
one would predict that positive regulators of NDR1/2, such as MOB1
[1], may also contribute to the DDR. Interestingly, this seems to be the
case, since MOB1A or MOB1B knockdown appears to be sufficient to
cause spontaneous DNA double-strand break formation in human
cells [45], proposing that the regulation of NDR1/2 by MOB1 might
also play a role in the DDR. However, whether NDR1/2 can function
upstream of MOB2 in cell cycle and/or DDR signaling is yet to be
established experimentally. The possible involvement of MOB1 in
NDR1/2-MOB2 signaling is also of purely speculative nature at the
moment, in particular when considering that MOB1 can associate with
different kinases of the Hippo core cassette such as LATS1/2 and
MST1/2 [1,3]. In this context, we also would like to emphasis the fact
that currently the molecular (structural) regulation of NDR1/2 kinases
by MOB1 vs. MOB2 is incompletely understood. Possibly, MOB2 is
part of positive and/or negative feedback loops that serve to amplify
and/or dampen cell cycle and/or DDR Signaling, respectively.
Certainly, these speculative points illustrate the need for more
intensified experimental efforts to understand MOB2 as a novel DDR
protein on the structural, molecular, cellular and organismal level in
the context of human biology in health and disease.
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